vidarabine phosphate has been researched along with Neutropenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athan, E; Fein, S; Fiedor, PS; Goodman, ER; Hardy, MA | 1 |
| Arima, N; Mizoguchi, H; Ohno, R; Shirakawa, S; Takatsuki, K; Tomonaga, M | 1 |
| Barlogie, B; Freireich, EJ; Kantarjian, H; Keating, MJ; Koller, C; McCredie, KB; Plunkett, W; Redman, J; Talpaz, M; Velasquez, W | 1 |
1 trial(s) available for vidarabine phosphate and Neutropenia
| Article | Year |
|---|---|
[Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Blood Cell Count; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Thrombocytopenia; Vidarabine Phosphate | 1999 |
2 other study(ies) available for vidarabine phosphate and Neutropenia
| Article | Year |
|---|---|
Fludarabine phosphate: A DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; B-Lymphocytes; Bone Marrow; Bone Marrow Cells; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; DNA; Endonucleases; Graft Survival; Humans; Immunization; Immunosuppressive Agents; Leukocytes, Mononuclear; Leukopenia; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Macaca fascicularis; Mitogens; Neutropenia; Papio; Phytohemagglutinins; Skin Transplantation; Swine; T-Lymphocytes; Vidarabine Phosphate | 1996 |
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neutropenia; Prognosis; Thrombocytopenia; Vidarabine Phosphate | 1989 |